Effect of sulpiride in endogenous depression

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Clinical practice and pharmacological data suggest potential antidepressant properties of sulpiride at low doses.
• Endogenous depression is a significant clinical challenge requiring effective treatment options.

Purpose of the Study:

• To investigate the therapeutic efficacy of low-dose oral sulpiride in patients with endogenous depression.
• To assess the onset of clinical improvement and changes in drive during sulpiride treatment.

Main Methods:

• A study involving 11 patients diagnosed with endogenous depression.
• Treatment administered: 150 mg oral daily dose of sulpiride.
• Observations focused on clinical progress, onset of improvement, and drive levels.

Main Results:

• Low-dose sulpiride demonstrated antidepressant effects in both severe and milder forms of depression.
• Clinical progress was observed earlier compared to conventional tricyclic antidepressant treatment.
• A significant increase in patient drive was a notable outcome.
• Sulpiride maintenance therapy did not prevent early relapse into depression.

Conclusions:

• Preliminary findings suggest low-dose sulpiride as a potential antidepressant with a rapid onset of action and positive impact on drive.
• The drug's efficacy in preventing relapse remains a concern, necessitating further investigation.
• The optimal patient population and comparative superiority of sulpiride over existing treatments require further clarification.